Skip to main content
. 2021 Nov 9;12(4):601–606. doi: 10.1016/j.jaim.2021.06.007

Fig. 3.

Fig. 3

A plate is showing QS inhibition of C. violaceum CV026 by formulation, where A-control and B (0.2 mg/ml), C (0.3 mg/ml), and D (0.4 mg/ml) show the anti-QS activity of the formulation.